FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Dec. 12, 2012--
MEDNAX, Inc., (NYSE: MD) today announced the acquisition of a
maternal-fetal medicine physician practice based in Lithia Springs,
Georgia. The practice will become part of MEDNAX’s Pediatrix Medical
Group division.
Raj K. Bansal, M.D., P.C., was established in 2002 and is a private
practice that consists of one maternal-fetal medicine physician and
eight clinical and administrative support staff who provide care to
expectant mothers, including the management of high-risk and complicated
pregnancies, throughout the Atlanta area. The practice provides
maternal-fetal services at five area hospitals, including Wellstar Cobb
Hospital, Wellstar Douglas Hospital, Wellstar Kennestone Hospital,
Piedmont Hospital and Atlanta Medical Center.
“Given the changing and uncertain healthcare environment, we felt that
now is the ideal time to partner with a leading national medical group
practice,” said Raj Bansal, M.D., who will serve as medical director for
the practice. “We look forward to experiencing the support of a national
administrative infrastructure that allows us the opportunity to spend
more time caring for our patients.”
Dr. Bansal will now be part of MEDNAX's Pediatrix Medical Group, a
national medical group consisting of the nation's leading neonatal,
maternal-fetal medicine, pediatric cardiology, and other pediatric
specialty physicians.
The practice was acquired for cash and the transaction is expected to be
immediately accretive to its earnings. No additional terms of the
transaction were disclosed.
With this acquisition, 13 physician group practices have become part of
MEDNAX in 2012, seven as part of Pediatrix Medical Group, and six as
part of American Anesthesiology.
ABOUT MEDNAX
MEDNAX, Inc. is a national medical group that comprises the nation's
leading provider of neonatal, maternal-fetal and pediatric physician
subspecialty services as well as anesthesia services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was
founded in 1979 and now includes neonatal physicians who provide
services at more than 300 neonatal intensive care units, who collaborate
with affiliated maternal-fetal medicine, pediatric cardiology and
pediatric critical care physician subspecialists to provide a clinical
care continuum. Pediatrix is also the nation's largest provider of
newborn hearing screens. In 2007, MEDNAX expanded into anesthesia
services. Today, American Anesthesiology includes more than 1,250
anesthesiologists and advanced practitioners who provide anesthesia care
to patients in connection with surgical and other procedures as well as
pain management. MEDNAX, through its affiliated professional
corporations, employs more than 1,925 physicians in 34 states and Puerto
Rico. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Exchange Commission.
Source: MEDNAX, Inc.
MEDNAX, Inc.
David T. Parker, 954-384-0175, x 5300
Vice
President, Investor Relations & Corporate Communications
david_parker@mednax.com